Histone deacetylase inhibitor for the treatment of hepatocellular carcinoma: Chemoimmunotherapeutic perspective and prospects

J Hepatol. 2017 Apr;66(4):866-867. doi: 10.1016/j.jhep.2016.11.029. Epub 2017 Jan 9.

Authors

Kaku Goto¹, Naoya Kato²

Affiliations

¹ The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
² The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan. Electronic address: [email protected].

PMID: 28082149
DOI: 10.1016/j.jhep.2016.11.029

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Carcinoma, Hepatocellular*
Cell Line, Tumor
Histone Deacetylase 1
Histone Deacetylase Inhibitors*
Histone Deacetylases
Humans
Hydroxamic Acids
Liver Neoplasms

Substances

Histone Deacetylase Inhibitors
Hydroxamic Acids
Histone Deacetylase 1
Histone Deacetylases